Kaizen Bioscience, Co. ('Kaizen') a ... Kaizen Bioscience Preparing Lead Asset for NDA Submission in 2025 ... San Antonio, TX. October 03, 2024. COPT ...
News
- Kaizen Bioscience Preparing Lead Asset for NDA Submission in 2025 | Business Wire
- bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024 - BioSpace
SAN ANTONIO--(BUSINESS WIRE)--#BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for ...
- Biotech firm could anchor $95M Cortex development - St. Louis Business Journal
San Antonio · San Francisco · Seattle · Silicon ... Biotech firm could anchor $95M Cortex development ... Fiorello did not name the prospective anchor ...
- Medicenna Announces Upcoming Presentations at the 29th Annual Meeting of the Society ...
... San Antonio Breast Cancer Symposium (SABCS), the world's largest breast ... Q3 Biotech Earnings Recap: Nkarta, Intellia, Cassava and more.
- MPM BioImpact Appoints Michael Ehlers, M.D., Ph.D., Experienced R&D Leader and ...
He will also remain on the Board of Directors of ATP portfolio companies Aulos Bioscience and Replicate Bioscience. ... San Antonio, TX. October 03, ...